Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$2.01B |
| 2 |
Broadcom
AVGO
|
+$1.41B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$978M |
| 4 |
JPMorgan Chase
JPM
|
+$714M |
| 5 |
Tesla
TSLA
|
+$626M |
Top Sells
| 1 |
Honeywell
HON
|
+$1.68B |
| 2 |
Visa
V
|
+$1.41B |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.22B |
| 4 |
Amazon
AMZN
|
+$855M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$550M |
Sector Composition
| 1 | Technology | 34.36% |
| 2 | Financials | 12.76% |
| 3 | Consumer Discretionary | 11.44% |
| 4 | Communication Services | 8.74% |
| 5 | Healthcare | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Symbotic
SYM
$5.44B
| $387K | ﹤0.01% |
9,965
+951
| +11% | +$36.9K |
|
3102
ChargePoint
CHPT
$235M
| $386K | ﹤0.01% |
27,440
-18,090
| -40% | -$254K |
|
3103
Monte Rosa Therapeutics
GLUE
$296M
| $386K | ﹤0.01% |
85,712
+39,502
| +85% | +$178K |
|
3104
Five Point Holdings
FPH
$412M
| $385K | ﹤0.01% |
70,087
| – | – |
|
3105
Baytex Energy
BTE
$1.83B
| $384K | ﹤0.01% |
214,550
-69,639
| -25% | -$125K |
|
3106
The Beauty Health Co
SKIN
$292M
| $383K | ﹤0.01% |
200,512
+119,742
| +148% | +$229K |
|
3107
ARK Genomic Revolution ETF
ARKG
$1.01B
| $379K | ﹤0.01% |
15,601
-20,774
| -57% | -$505K |
|
3108
Expensify
EXFY
$174M
| $378K | ﹤0.01% |
146,015
-25,119
| -15% | -$65K |
|
3109
SELLAS Life Sciences
SLS
$198M
| $378K | ﹤0.01% |
+172,803
| New | +$378K |
|
3110
Inspired Entertainment
INSE
$250M
| $377K | ﹤0.01% |
46,130
+21,020
| +84% | +$172K |
|
3111
Norwood Financial Corp
NWFL
$245M
| $377K | ﹤0.01% |
14,641
+6,245
| +74% | +$161K |
|
3112
Pure Cycle
PCYO
$266M
| $377K | ﹤0.01% |
35,256
+14,313
| +68% | +$153K |
|
|
SEPN
3113
Septerna, Inc. Common Stock
SEPN
$656M
| $377K | ﹤0.01% |
35,706
+12,973
| +57% | +$137K |
|
3114
PCB Bancorp
PCB
$308M
| $376K | ﹤0.01% |
17,922
+7,012
| +64% | +$147K |
|
3115
Anika Therapeutics
ANIK
$121M
| $374K | ﹤0.01% |
35,390
+7,379
| +26% | +$78K |
|
|
ESSA
3116
DELISTED
ESSA Bancorp
ESSA
| $374K | ﹤0.01% |
19,268
+4,702
| +32% | +$91.3K |
|
3117
Omeros
OMER
$291M
| $374K | ﹤0.01% |
124,831
+43,490
| +53% | +$130K |
|
3118
Paymentus
PAY
$4.41B
| $374K | ﹤0.01% |
11,453
+5,838
| +104% | +$191K |
|
3119
NACCO Industries
NC
$293M
| $372K | ﹤0.01% |
8,414
+2,665
| +46% | +$118K |
|
3120
Puma Biotechnology
PBYI
$229M
| $372K | ﹤0.01% |
108,653
+25,392
| +30% | +$86.9K |
|
3121
First United
FUNC
$236M
| $370K | ﹤0.01% |
11,929
-1,044
| -8% | -$32.4K |
|
3122
Design Therapeutics
DSGN
$349M
| $368K | ﹤0.01% |
109,536
+25,530
| +30% | +$85.8K |
|
3123
FVCBankcorp
FVCB
$240M
| $368K | ﹤0.01% |
31,293
+14,509
| +86% | +$171K |
|
3124
Sky Harbour Group
SKYH
$339M
| $368K | ﹤0.01% |
37,688
+25,145
| +200% | +$246K |
|
3125
Aldeyra Therapeutics
ALDX
$333M
| $367K | ﹤0.01% |
95,648
+44,691
| +88% | +$171K |
|